Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026)
Q32 Bio's (QTTB) quarterly Other Working Capital Changes came in at -$168000.0 in Q1 2026, down 12.75% year-on-year from -$192553.8 in Q1 2025, and down 7.01% quarter-over-quarter from -$157000.0 in Q4 2025.
Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Q32 Bio's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$168000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 12.75% year-over-year to -$168000.0 in Q1 2026; TTM through Mar 2026 was -$631000.0, a 65.02% increase from a year earlier, with the FY2025 full-year figure at -$612000.0, up 60.31% from the prior year.
- Other Working Capital Changes eased to -$168000.0 in Q1 2026 per QTTB's latest filing, from -$157000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.6 million in Q2 2022 and bottomed at -$25.7 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$507000.0 (2022), against an average of -$1.7 million.
- Across the five-year window, Other Working Capital Changes jumped 97.24% in 2022 and tumbled 372.73% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$802000.0 in 2022, then surged by 84.91% to -$121000.0 in 2023, then slumped by 372.73% to -$572000.0 in 2024, then jumped by 72.55% to -$157000.0 in 2025, then decreased by 7.01% to -$168000.0 in 2026.
- Per Business Quant, the three latest QTTB Other Working Capital Changes figures stand at -$168000.0 (Q1 2026), -$157000.0 (Q4 2025), and -$155000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Jun 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 343,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Dec 31, 2024 | -908,000.00 |
| Dec 31, 2024 | -908,000.00 |
| Dec 31, 2024 | -908,000.00 |
| Sep 30, 2024 | 847,000.00 |
| Sep 30, 2024 | 847,000.00 |